GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: EYEOO1 | Macugen® | NX183 | pegaptanib sodium
pegaptanib is an approved drug (FDA (2004), EMA (2006))
Compound class:
Nucleic acid
Comment: Pegaptanib is a RNA oligonucleotide aptamer that acts as a vascular endothelial growth factor A antagonist, anti-angiogenic agent.
It is a 28-mer RNA oligonucleotide that is covalently linked to two branched 20-kD polyethylene glycol (PEG) chains. Pegaptanib binds to the 165 isoform of VEGFA. It is formulated as a sodium adduct. The basic nucleotide sequence has modified nucleotides and a 5' pentylamino linker that acts as the PEG anchor. |
|
|||||||||
Classification ![]() |
|
| Compound class | Nucleic acid |
| Compound subclass | Aptamer |
| Target | Vascular endothelial growth factor A |
| Approved drug? | Yes. US FDA (2004) | EU EMA (2006) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8215 | pegaptanib |
Synonyms ![]() |
| EYEOO1 | Macugen® | NX183 | pegaptanib sodium |
Database Links ![]() |
|
| Specialist databases | |
Reactome Drug
|
R-ALL-9679463 |
Reactome Reaction
|
R-HSA-9679477 |
| Other databases | |
| CAS Registry No. | 222716-86-1 (source: WHO INN record) |
| DrugBank Ligand | DB04895 |
| GtoPdb PubChem SID | 178103442 |
| Search PubMed clinical trials | pegaptanib |
| Search PubMed titles | pegaptanib |
| Search PubMed titles/abstracts | pegaptanib |
| Wikipedia | Pegaptanib |